Further, PGC-1α expression markedly increased in the majority of tumor series derived from distinct donor tissue series, with a sudden drop in PGC-1α expression levels in two patient series (P3 and P10) upon development of the POU2F3/ASCL2 subtype (Fig. 2C). Here, PPARGC1A is linked to neoplasm.